Capital Group Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
4,068
-1,883
-32% -$645K 0.22% 91
2026
Q1
$2.09M Buy
5,951
+162
+3% +$57.8K 0.36% 77
2025
Q4
$1.89M Sell
5,789
-5,943
-51% -$1.89M 0.31% 80
2025
Q3
$3.31M Buy
11,732
+5,666
+93% +$1.64M 0.55% 51
2025
Q2
$1.69M Buy
6,066
+169
+3% +$47.9K 0.3% 83
2025
Q1
$1.84M Buy
+5,897
New +$1.74M 0.38% 75
2024
Q2
– Sell
-4,872
Closed -$1.39M – 142
2024
Q1
$1.39M Buy
+4,872
New +$1.43M 0.25% 104

Other funds holding AMGN

Capital Group Investment Management's AMGN Position: Q2 2026 in Review

Capital Group Investment Management reduced its Amgen (AMGN) stake by 32% in Q2 2026, selling an estimated $645K and leaving 4,068 shares worth $1.47M. The position accounts for 0.22% of the portfolio, ranked #91.

Capital Group Investment Management first reported a position in AMGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.31M in Q3 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Group Investment Management held 4,068 shares of Amgen worth $1.47M as of Q2 2026.
  • Capital Group Investment Management sold 1,883 Amgen shares in Q2 2026, an estimated $645K.
  • Amgen made up 0.22% of Capital Group Investment Management's portfolio in Q2 2026, its #91 holding.
  • Capital Group Investment Management first reported a position in Amgen in Q1 2024 and has held it in 7 quarters since.
  • Capital Group Investment Management's Amgen position peaked at $3.31M in Q3 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.